Search Results

There are 14913 results for: content related to: Acute and severe acne in a patient treated with bevacizumab

  1. You have free access to this content
    Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas

    Cancer

    Volume 116, Issue 17, 1 September 2010, Pages: 3988–3999, Marc C. Chamberlain

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25256

  2. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

    British Journal of Surgery

    Volume 98, Issue 3, March 2011, Pages: 399–407, D. A. Wicherts, R. J. de Haas, M. Sebagh, E. Saenz Corrales, D. L. Gorden, F. Lévi, B. Paule, D. Azoulay, D. Castaing and R. Adam

    Article first published online : 15 DEC 2010, DOI: 10.1002/bjs.7368

  3. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 247–255, Jignesh J. Patel, Margaret A.S. Mendes, Mark Bounthavong, Melissa L.D. Christopher, Daniel Boggie and Anthony P. Morreale

    Article first published online : 16 SEP 2010, DOI: 10.1111/j.1365-2753.2010.01546.x

  4. Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery

    Acta Ophthalmologica

    Tine Van Bergen, Evelien Vandewalle, Lieve Moons and Ingeborg Stalmans

    Article first published online : 18 MAY 2015, DOI: 10.1111/aos.12766

  5. Anti-angiogenic therapies for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea ADW Wagner, Dirk Arnold, Axel AG Grothey, Johannes Haerting and Susanne Unverzagt

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD005392.pub3

  6. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 726–734, Axel Grothey, E. Dawn Flick, Allen L. Cohn, Tanios S. Bekaii-Saab, Johanna C. Bendell, Mark Kozloff, Nancy Roach, Yong Mun, Susan Fish and Herbert I. Hurwitz

    Article first published online : 16 MAY 2014, DOI: 10.1002/pds.3633

  7. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  8. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  9. Bevacizumab (Avastin)

    Handbook of Therapeutic Antibodies

    Eduardo Díaz-Rubio, Edith A. Perez, Guiseppe Giaccone, Pages: 779–812, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch29

  10. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  11. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting and Susanne Unverzagt

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD008941.pub2

  12. A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 3, May/June 2008, Pages: 400–406, J.D. WRIGHT, A.A. SECORD, T.M. NUMNUM, R.P. ROCCONI, M.A. POWELL, A. BERCHUCK, R.D. ALVAREZ, R.K. GIBB, K. TRINKAUS, J.S. RADER and D.G. MUTCH

    Article first published online : 21 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01027.x

  13. You have free access to this content
    Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: e304–e310, Yu Xu, Qi Zhang, Xiaoli Kang, Ying Zhu, Jiakai Li, Yiye Chen and Peiquan Zhao

    Article first published online : 7 MAY 2013, DOI: 10.1111/aos.12055

  14. Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab

    Clinical & Experimental Ophthalmology

    Taraprasad Das, Srinivas Volety, Saad M Ahsan, Abhay K Thakur, Savitri Sharma, Tapas R Padhi, Soumyava Basu and Ch Mohan Rao

    Article first published online : 14 APR 2015, DOI: 10.1111/ceo.12489

  15. Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

    Cancer

    Volume 121, Issue 9, May 1, 2015, Pages: 1456–1462, Jim Zhong, Arif N. Ali, Alfredo D. Voloschin, Yuan Liu, Walter J. Curran Jr, Ian R. Crocker and Hui-Kuo G. Shu

    Article first published online : 29 DEC 2014, DOI: 10.1002/cncr.29234

  16. Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas

    Pediatric Blood & Cancer

    Volume 60, Issue 5, May 2013, Pages: 776–782, Eugene I. Hwang, Regina I. Jakacki, Michael J. Fisher, Lindsay B. Kilburn, Marianna Horn, Gilbert Vezina, Brian R. Rood and Roger J. Packer

    Article first published online : 13 SEP 2012, DOI: 10.1002/pbc.24297

  17. Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Cancer

    Volume 121, Issue 7, April 1, 2015, Pages: 997–1007, Kathryn M. Field, Justin T. Jordan, Patrick Y. Wen, Mark A. Rosenthal and David A. Reardon

    Article first published online : 26 SEP 2014, DOI: 10.1002/cncr.28935

  18. Antiangiogenic therapy for high-grade glioma

    Intervention Review

    The Cochrane Library

    Mustafa Khasraw, Malaka S Ameratunga, Robin Grant, Helen Wheeler and Nick Pavlakis

    Published Online : 22 SEP 2014, DOI: 10.1002/14651858.CD008218.pub3

  19. You have free access to this content
    Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

    Cancer

    Volume 119, Issue 5, 1 March 2013, Pages: 1042–1049, Manon Buijs, Diane K. Reyes, Timothy M. Pawlik, Amanda L. Blackford, Riad Salem, Wells A. Messersmith, Colin D. Weekes, Mary Mulcahy, Ihab R. Kamel and Jean-Francois H. Geschwind

    Article first published online : 6 NOV 2012, DOI: 10.1002/cncr.27859

  20. Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends

    Pediatric Blood & Cancer

    Volume 59, Issue 1, 15 July 2012, Pages: 34–38, Marie-Laure Couec, Nicolas André, Estelle Thebaud, Odile Minckes, Xavier Rialland, Nadège Corradini, Isabelle Aerts, Perrine Marec Bérard, Franck Bourdeaut, Pierre Leblond and on the behalf of the Comité Pharmacologie of the SFCE

    Article first published online : 27 JAN 2012, DOI: 10.1002/pbc.24066